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S U M M A R Y
Objectives: To identify the role of single nucleotide polymorphisms (SNPs) of the tumor necrosis factor
(TNF) gene in the natural course of 2009 inﬂuenza A H1N1 virus infection.
Methods: Genomic DNA was isolated from 109 patients with an H1N1 infection and from 108 healthy
volunteers. SNPs of the TNF gene were assessed after electrophoresis of the digested PCR products by
restriction enzymes.
Results: The frequency of the 238 A allele was signiﬁcantly greater among patients than among
controls. Viral pneumonia developed in 20 of 96 non-carriers of at least one 238 A allele (20.8%) and in
seven of 13 carriers of at least one 238 A allele (53.8%, p = 0.016). Logistic regression analysis showed
that the most important factors associated with the development of pneumonia were the presence of an
underlying disease (p = 0.021, odds ratio (OR) 3.08) and the carriage of at least one 238 A allele
(p = 0.041, OR 3.74). Gene transcripts of the TNF gene were greater among non-carriers of the 238 A
allele than among carriers of the 238 A allele.
Conclusions: The 238 A SNP allele of the TNF gene imposes on the course of 2009 H1N1 virus infection
and is an independent risk factor for pneumonia.
 2012 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
International Journal of Infectious Diseases
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The pandemic caused by the new inﬂuenza A H1N1 virus that
lasted from May 2009 until early spring 2010 created a difﬁcult
situation worldwide with immense effects on daily lives and on the
world economy. This pandemic involved 214 countries and
resulted in over 18 156 deaths.1 The infection was rather self-
limiting, with symptoms of illness of the upper respiratory tract.
The ubiquitous characteristic of this H1N1 pandemic compared
with other inﬂuenza A pandemics was the occurrence of more
severe cases among young individuals. Severity was deﬁned by the
advent of pulmonary complications, namely pneumonia, acute
lung injury (ALI), and adult respiratory distress syndrome (ARDS).
These were also described in pregnant women and among
individuals with underlying diseases such as obesity, bronchial
asthma, and heart failure.2
Viral infections are in general self-contained after activation of
the innate immune defense. Viral particles are recognized by
pattern recognition receptors of the innate immune cells, mainly* Corresponding author. Tel.: +30 210 58 31 994; fax: +30 210 53 26 446.
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pro-inﬂammatory cytokines such as tumor necrosis factor alpha
(TNF-a), interleukin (IL)-1b, IL-6, and IL-8. The latter cytokines
orchestrate the host’s defense, not only against the offending virus,
but also against superimposed bacterial pathogens. The latter
pathogens often lead to superinfections.3 In a recent study by our
group, peripheral blood mononuclear cells (PBMCs) were isolated
from 31 patients infected with the 2009 H1N1 virus and stimulated
ex vivo with a variety of stimuli. Results revealed defective release
of TNF-a and of interferon-gamma (IFN-g) after stimulation with
heat-killed Streptococcus pneumoniae compared with the
responses of PBMCs from healthy volunteers and from patients
suffering from a ﬂu-like syndrome.4
The genes of many cytokines implicated in the innate immune
response of the human host present single nucleotide polymor-
phisms (SNPs). It has been reported that many of these SNPs
modify the susceptibility of the host to an infection.5–7 Regarding
the TNF gene, three SNPs have been described, all at different
locations within the promoter region: a substitution of guanine by
adenine at the 376 position (376 TNF G/A, rs1800750), a
substitution of guanine by adenine at the 308 position (308 TNF
G/A, rs1800629), and a substitution of guanine by adenine at the
238 position (238 TNF G/A, rs361525). The exact clinicalses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Agarose gel electrophoresis of PCR products of the TNF gene regions of
patients infected by the 2009 H1N1 virus after digestion with the indicated
restriction enzymes. Figures are indicative of the visualization of the PCR digested
products presented in Table 1.
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these SNPs does not seem to affect TNF-a production. However,
susceptibility to infection seems to be affected. It has been
reported that carriage of these SNPs predisposes to a worse
outcome among patients infected with HIV and with the hepatitis
C virus.8
No evidence linking the carriage of SNPs of the TNF gene with
susceptibility to viral infections or with susceptibility to bacterial
superinfection after viral inﬂuenza is available. However our
previous ﬁndings point towards considerable down-regulation of
TNF-a production by the PBMCs of patients infected with the 2009
H1N1 virus.4 This prompted us to investigate if SNPs of the TNF
gene may have some impact on the course of 2009 H1N1 virus
infection.
2. Patients and methods
2.1. Study design
The study was performed during the period July–November
2009. The study protocol was approved by the Ethics Committee of
ATTIKON University Hospital, Athens. All patients admitted to the
emergency department for ﬂu-like symptoms and who provided
written informed consent were eligible for inclusion.
Inclusion criteria were: (1) written informed consent; (2) age
16 years; (3) conﬁrmed diagnosis of H1N1 infection by real-time
PCR as described below; (4) core temperature above 38 8C; and (5)
Greek citizens of Caucasian origin. Core temperature above 38 8C
was used to detect patients with more severe disease, as most
cases of infection with the 2009 H1N1 virus were mild or self-
limiting. Exclusion criteria were: (1) refusal to consent; (2) known
HIV infection; (3) neutropenia, deﬁned as an absolute neutrophil
count 500 neutrophils/mm3 of blood; (4) oral intake of
corticosteroids, deﬁned as more than 1 mg/kg body weight of
equivalent prednisone for more than 1 month.
Enrolled patients underwent a detailed work-up, comprising
case history and epidemiological history, a thorough physical
examination, chest X-ray if considered necessary, white blood cell
count, and urine analysis for the detection of leukocytes and nitrate
and detection of antigens of S. pneumoniae and of Legionella
pneumophila. If the above work-up failed to disclose the presence
of a bacterial infection, a pharyngeal smear was collected with a
swab. Infection with the H1N1 virus was diagnosed by real-time
reverse transcriptase polymerase chain reaction detecting the
presence of H1N1 RNA in the infected cells (rRT-PCR), as approved
for European countries and applied in Greece.9 A patient was
considered to have viral pneumonia due to H1N1 when a local
inﬁltrate was diagnosed on chest X-ray and H1N1 RNA was
detected in the pharyngeal swab, as deﬁned elsewhere.10–12
Diagnosis of ALI and of ARDS was done according to well
established deﬁnitions.13,14 Patients were followed-up until
complete resolution of symptoms. Body mass index (BMI) was
calculated for all patients using the standard formula. Those with a
BMI above 30 kg/m2 were considered to be obese.15 The presence
of any underlying diseases was also recorded.
In parallel with the collection of the pharyngeal smear, 3 ml of
whole blood was drawn after venipuncture of one forearm
antecubital vein under sterile conditions and collected into one
ethylenediaminetetraacetic acid (EDTA)-coated tube (Vacutainer,
Becton Dickinson, Cockeysville, MD, USA) for DNA extraction.
A similar amount of blood was drawn from 108 healthy Greek
donors of Caucasian origin after informed consent during the
period February–June 2007, before the advent of the 2009 H1N1
virus. SNPs of the TNF gene of these patients were used as a control
group.2.2. Laboratory techniques
Genomic DNA was extracted from whole blood with the
Purigen Blood Core Kit C (Qiagen) in accordance with the
manufacturer’s instructions. PCR reactions were performed in a
Sensoquest apparatus (Go¨ttingen, Germany) using 50 ng of
genomic DNA at a ﬁnal volume of 27 ml with 50 mM MgCl2
(New England BioLabs, Ipswich, MA, USA), 20 mM dNTPs (New
England BioLabs), and 1 mM Taq polymerase (New England
BioLabs). The selection of primers for SNP alleles of the TNF gene
and conditions of PCR were based on previous publications.16,17 For
the 376 G/A TNF SNP, the sense primer 50-CCT CAG GAC TCA ACA
CAG C-30 and the antisense primer 50-GGG GAC CAG GTC TGT GGT
CTG TTT CCT GTT AA-30 were used. PCR consisted of one initial
denaturation phase of 95 8C for 10 min, followed by 35 cycles; each
cycle consisted of one annealing step of 95 8C for 1 min, one
polymerization step of 58 8C for 1 min, and one elongation step of
72 8C for 1 min. Then another cycle of 72 8C for 7 min was done
before termination. The ﬁnal PCR product was 148 bp. Ten
microliters of the PCR product were digested after incubation
for 4 h at 37 8C with 0.5 U of the restriction enzyme HpaI (New
England BioLabs); they were visualized after 2% agarose gel
electrophoresis and ethidium bromide staining and evaluated after
comparison with appropriate controls. If the restriction reaction
yielded one 148-bp fragment, the presence of the A allele was
conﬁrmed; if the reaction yielded two fragments, one of 118 bp
and another of 30 bp, the presence of the G allele was conﬁrmed
(Figure 1). Evaluation was done after comparisons with the
digestion products of the PCR of one known sample bearing the GA
phenotype and serving as positive control.
For the 308 G/A TNF SNP, the sense primer 50-GAG GCA ATA GGT
TTT GAG GGC CAT-30 and the antisense primer 50-GGG ACA CAC AAG
CAT CAA G-30 were used. PCR consisted of one initial denaturation
phase of 95 8C for 10 min, followed by 35 cycles; each cycle consisted
of one annealing step of 94 8C for 1 min, one polymerization step of
60 8C for 1 min, and one elongation step of 72 8C for 1 min. Then
another cycle of 72 8C for 7 min was done before termination. The
ﬁnal PCR product was 147 bp. Ten microliters of the PCR product
were digested after incubation for 4 h at 37 8C with 0.5 U of the
restriction enzyme NcoI (New England BioLabs); they were
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bromide staining and evaluated after comparison with appropriate
controls. If the restriction reaction yielded one 147-bp fragment, the
presence of the A allele was conﬁrmed; if the reaction yielded two
fragments, one of 121 bp and another of 26 bp, the presence of the G
allele was conﬁrmed (Figure 1). Evaluation was done after
comparisons with the digestion products of the PCR of one known
sample bearing the GA phenotype and serving as positive control.
For the 238 G/A TNF SNP, the sense primer 50-CAG ACC ACA
GAC CTG GTC-30 and the antisense primer 50-AAG GAT ACC CCT
CAC ACT CCC CAT CCT CCC GGA TC-30 were used. PCR consisted of
one initial denaturation phase of 95 8C for 10 min, followed by 35
cycles; each cycle consisted of one annealing step of 95 8C for
1 min, one polymerization step of 58 8C for 1 min, and one
elongation step of 72 8C for 1 min. Then another cycle of 72 8C for
7 min was done before termination. The ﬁnal PCR product was
165 bp. Ten microliters of the PCR product were digested after
incubation for 4 h at 37 8C with 0.5 U of the restriction enzyme
BamHI (New England BioLabs); they were visualized after 2%
agarose gel electrophoresis and ethidium bromide staining and
evaluated after comparison with appropriate controls. If the
restriction reaction yielded one 165-bp fragment, the presence of
the A allele was conﬁrmed; if reaction yielded two fragments, one
of 123 bp and another of 42 bp, the presence of the G allele was
conﬁrmed (Figure 1). Evaluation was done after comparisons with
the digestion products of the PCR of one patient bearing the GA
phenotype and serving as positive control.
2.3. Gene expression of TNF-a
Gene expression of TNF-a was assessed in PBMCs isolated from
19 patients admitted within less than 24 h of presentation with
fever, as deﬁned by their case history. PBMCs were isolated after
gradient centrifugation of heparinized blood over Ficoll. After three
washings with ice-cold phosphate-buffered saline pH 7.2 (Bio-
chrom, Berlin, Germany) and trypan blue exclusion of dead cells,
PBMCs were lyzed with Trizol (Invitrogen, Karlsruhe, Germany).
RNA was extracted after chloroform gradient centrifugation and
subsequent treatment with 0.04 U/ml of DNAase (New England
BioLabs). For the production of cDNA, 1.5 mg of RNA of each sample
was applied as previously described18 after addition of reverse
transcriptase (Invitrogen) using blanks without the addition of
reverse transcriptase.
Expression of mRNA of TNF-a for each sample was performed
using the iCycler system (BioRad) using b2-microglobulin as a
housekeeping gene and the sense and antisense primers and theTable 1
Distribution of genotypes of the single nucleotide polymorphisms (SNPs) of the promote
H1N1 virus infection and among 108 controls
SNP Genotype Patients with
pneumonia, n (%)
p-Value for patients 
pneumonia vs. contro
376 G/A GG 25 (92.6) 
GA 2 (7.4) 
AA 0 (0) 
G allele 52 (96.3) 0.102 
A allele 2 (3.7) 
308 G/A GG 22 (81.5) 
GA 4 (14.8) 
AA 1 (3.7) 
G allele 48 (88.9) 0.261 
A allele 6 (11.1) 
238 G/A GG 20 (74.1) 
GA 7 (25.9) 
AA 0 (0) 
G allele 47 (87.0) <0.0001 
A allele 7 (13.0) conditions already described.18 Quantitative results were
expressed as the ratio of transcripts of TNF-a to b2-microglobulin.
2.4. Statistical analysis
The primary endpoint was the impact of the studied SNPs on
susceptibility to infection with the 2009 H1N1 virus. To this end,
comparisons between H1N1-infected patients and controls were
done by Chi-square test. The secondary endpoint was the impact of
the studied SNPs on the development of viral pneumonia. To this
end, logistic regression analysis was performed, with the advent of
pneumonia as a dependent variable and gender, carriage of SNP
alleles, and the presence of at least one underlying disease as
independent variables. The role of each independent variable was
assessed in a forward conditional model. Obesity, chronic heart
failure, allergic bronchial asthma, chronic obstructive pulmonary
disease, and pregnancy were considered the most imposing
underlying diseases, according to published ﬁndings.13,14 Odds
ratios (OR) and 95% conﬁdence intervals (CI) were estimated. Any p-
value below 0.05 was considered signiﬁcant after adjustment for
multiple comparisons.
3. Results
During the study period, 109 patients were enrolled in the
study; 54 were male and 55 female. Of the 108 controls, 63 were
male and 45 female (p = not signiﬁcant).
The distribution of each of the studied SNP alleles is shown in
Table 1. Alleles were in Hardy–Weinberg equilibrium. Nineteen
patients were carriers of at least one 308 A SNP allele compared
with 16 of the control population. Thirteen patients infected with
the 2009 H1N1 virus were carriers of at least one 238 A SNP allele.
The frequency of that allele was signiﬁcantly greater among
patients than among controls. Twenty-seven patients infected
with the 2009 H1N1 virus developed pneumonia; ﬁve progressed
to ALI/ARDS. The frequency of the 238 A SNP allele was also
signiﬁcantly greater among patients who developed pneumonia
compared with controls. More precisely, pneumonia developed in
20 among 96 non-carriers of at least one 238 A allele (20.8%) and
in seven among 13 carriers of at least one 238 A allele (53.8%,
p = 0.016 between carriers and non-carriers). No patient died.
Logistic regression analysis showed that the most important
factors associated with the development of pneumonia were the
presence of an underlying disease (p = 0.021, OR 3.08, 95% CI 1.18–
8.08) and the carriage of at least one 238 A allele (p = 0.041, OR





Controls, n (%) p-Value for total
patients vs. controls
107 (98.2) 107 (99.1)
2 (1.8) 1 (0.9)
0 (0) 0 (0)
216 (99.1) 215 (99.5) 0.503
2 (0.9) 1 (0.5)
87 (79.8) 92 (85.2)
19 (17.4) 14 (12.9)
3 (2.8) 2 (1.9)
193 (88.5) 198 (91.7) 0.089
25 (11.5) 18 (8.3)
96 (88.1) 104 (96.3)
12 (11.0) 4 (3.7)
1 (0.9) 0 (0)
204 (93.6) 212 (98.1) 0.016
14 (6.4) 4 (1.9)
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from 19 patients; 16 were GG homozygous for the 238 G allele
and three were GA heterozygous for the 238 SNPs. Mean 
standard error of the TNF-a transcripts relative to b2-microglobulin
transcripts were 25.9  16.8 and 1.8  0.8, respectively.
4. Discussion
The signiﬁcance of the carriage of any of the three SNPs of the
promoter region of the TNF gene for predisposition to an infection
or for the clinical presentation of an infection has not been fully
elucidated. Published studies have focused on patients with sepsis
and have presented controversial ﬁndings. Among the three
known SNPs, the role of the 308G/A SNP at the promoter region of
the TNF gene is the most broadly studied.
The existing studies are divided into two types: those with
genotyping performed among patients at high risk for infection
and the link of infection with carriage of the 308 G/A SNP allele as
a ﬁnal outcome, and those with genotyping performed among
patients with sepsis and the link of disease severity with carriage of
the 308 G/A SNP allele as a ﬁnal outcome. The former type of
study has comprised cohorts of patients with burns, patients
undergoing esophagectomy, and mechanically ventilated very low
birth weight infants who were followed-up for the advent of
infective sequelae. In the ﬁrst cohort of 159 patients with extensive
burn injuries, those who were carriers of the A allele had a 41% risk
for severe sepsis compared with 17% of patients homozygous for
the wild-type G allele (p = 0.002).19 In contrast, results from the
cohort of 179 patients undergoing esophagectomy revealed a
greater rate of post-operative infections among patients homozy-
gous for the wild-type G allele.20 Among 173 very low birth weight
infants who were mechanically ventilated, the presence of the A
allele was associated with a greater mortality from sepsis
compared with those homozygous for the wild-type G allele, an
effect pronounced among infants with bacteremia and fungemia.21
Two more prospective studies have been performed in patients
with sepsis: one enrolling 213 patients with severe sepsis and/or
septic shock,22 and another enrolling 319 septic patients of whom
214 presented with sepsis, 60 with severe sepsis, and 21 with
septic shock.23 Both studies failed to disclose any association
between the presence of the A allele and disease severity or ﬁnal
outcome.
In an attempt to disclose the existence of any association
between carriage of the 308 A allele and the advent of sepsis, a
meta-analysis of 25 studies has recently been published. Patients
included in this meta-analysis developed sepsis in the ﬁeld of a
variety of underlying conditions, namely multiple traumas and
surgical operations. A positive association was found between
carriage of the 308 A allele and a predisposition to sepsis. This
was particularly pronounced among patients of Asian ethnicity; no
linkage to ﬁnal outcome was found.24 However, the impact of
carriage of the 238 A allele was not reported.
In the present study in a cohort of patients with 2009 H1N1
virus infection of moderate to high severity, carriage of SNP alleles
of the TNF gene was signiﬁcantly greater than in the control
population. This observation was particularly pronounced for the
238 A allele, leading to the hypothesis that carriage of this SNP
allele may be associated with increased susceptibility to infection
with the 2009 H1N1 virus.
The salient ﬁnding of the present study was an association
between carriage of the 238 A SNP allele and the occurrence of
pulmonary complications. The signiﬁcance of this ﬁnding is
underscored by four key points: (1) the effect of SNPs of the
TNF gene is shown even with a study enrolling a relatively small
number of patients; (2) enrolled patients had disease either of
moderate severity or of considerable severity, since they allpresented with fever above 38.0 8C, whereas pneumonia was
diagnosed in 27; (3) the mean age of enrolled patients was within
the age range reported for young individuals with pneumonia
complications; and (4) carriage of the 238 A allele was found to
be an independent risk factor for susceptibility of the studied
cohort to pneumonia. This independent risk factor curtails its
statistical signiﬁcance even in the presence of well-deﬁned
predisposing conditions for pneumonia like obesity, bronchial
asthma, heart failure, chronic obstructive pulmonary diseases, and
pregnancy. The latter factors have been epidemiologically associ-
ated with a predisposition to viral pneumonia.2,16,17
Although the former studies did not show any effect of SNPs on
ex vivo release of TNF-a,8 gene copies of TNF-a were assessed in
PBMCs of patients at the early stage of symptoms. Results disclosed
a greater number of gene copies among non-carriers of SNPs. This
may explain how SNP carriage linked to lower production of TNF-a
may predispose to more severe clinical presentations of H1N1
infection.
The presented ﬁndings should be interpreted with caution in
light of the following study limitations: (1) the number of enrolled
patients is small compared with the high frequency of 2009 H1N1
inﬂuenza cases. Although study enrolment was limited to more
severe cases, it succeeded in unraveling the signiﬁcance of the
238 A SNP allele; (2) linkage between the 238 A SNP and
development of pneumonia may be a characteristic of a speciﬁc
geographic region and results should be conﬁrmed in another
cohort. This conﬁrmatory analysis should not be limited to a few
gene SNPs but should focus on the patients’ whole genome.
The presented results revealed that carriage of the 238 A SNP
allele of the TNF gene imposed considerably on the natural course
of 2009 H1N1 virus infection. Carriage of this allele was
independently associated with the advent of pulmonary complica-
tions, namely viral pneumonia and ALI/ARDS. These ﬁndings may
help explain the severe pulmonary complications among young
individuals infected with the 2009 H1N1 virus in contrast to
former pandemics in which viral pneumonias have usually affected
older people.
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